imigran nefúði, lausn 20 mg/skammt
glaxosmithkline pharma a/s - sumatriptanum inn - nefúði, lausn - 20 mg/skammt
imigran radis filmuhúðuð tafla 100 mg
glaxosmithkline pharma a/s - sumatriptanum súkkínat - filmuhúðuð tafla - 100 mg
imigran radis filmuhúðuð tafla 50 mg
glaxosmithkline pharma a/s - sumatriptanum súkkínat - filmuhúðuð tafla - 50 mg
azitromicina normon filmuhúðuð tafla 500 mg
laboratorios normon s.a. - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg
trandate filmuhúðuð tafla 100 mg
aspen pharma trading limited - labetalolum hýdróklóríð - filmuhúðuð tafla - 100 mg
trandate filmuhúðuð tafla 200 mg
aspen pharma trading limited - labetalolum hýdróklóríð - filmuhúðuð tafla - 200 mg
trandate stungulyf, lausn 5 mg/ml
aspen pharma trading limited - labetalolum hýdróklóríð - stungulyf, lausn - 5 mg/ml
imigran stungulyf, lausn 12 mg/ml
glaxosmithkline pharma a/s - sumatriptanum súkkínat - stungulyf, lausn - 12 mg/ml
aquipta
abbvie deutschland gmbh & co. kg - atogepant - mígreni kvilla - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
vyepti
h. lundbeck a/s - eptinezumab - mígreni kvilla - verkjalyf - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.